MSH Capital Advisors’s Amgen AMGN Stock Holding History

MSH Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$338K	Buy	960 +277	+41%	+$98.7K	0.07%	216
2025 Q4	$224K	Buy	+683	New	+$217K	0.05%	253
2022 Q4	–	Sell	-5,329	Closed	-$1.2M	–	195
2022 Q3	$1.2M	Buy	5,329 +25	+0.5%	+$6.06K	0.59%	59
2022 Q2	$1.29M	Sell	5,304 -102	-2%	-$25K	0.6%	60
2022 Q1	$1.31M	Buy	5,406 +210	+4%	+$48.3K	0.54%	63
2021 Q4	$1.17M	Buy	+5,196	New	+$1.1M	0.52%	64

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

MSH Capital Advisors's AMGN Position: Q1 2026 in Review

MSH Capital Advisors increased its Amgen (AMGN) stake by 41% in Q1 2026, buying an estimated $98.7K and bringing the position to 960 shares worth $338K. The position accounts for 0.07% of the portfolio, ranked #216.

MSH Capital Advisors first reported a position in AMGN in Q4 2021 and has held it in 6 quarters since. The position peaked at $1.31M in Q1 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

MSH Capital Advisors held 960 shares of Amgen worth $338K as of Q1 2026.
MSH Capital Advisors bought 277 Amgen shares in Q1 2026, an estimated $98.7K.
Amgen made up 0.07% of MSH Capital Advisors's portfolio in Q1 2026, its #216 holding.
MSH Capital Advisors first reported a position in Amgen in Q4 2021 and has held it in 6 quarters since.
MSH Capital Advisors's Amgen position peaked at $1.31M in Q1 2022.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.